Assura PLC
LSE:AGR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (19.4), the stock would be worth GBX47.43 (0% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 19.4 | GBX47.48 |
0%
|
| 3-Year Average | 19.4 | GBX47.43 |
0%
|
| 5-Year Average | 19.7 | GBX48.13 |
+1%
|
| Industry Average | 0.1 | GBX0.19 |
-100%
|
| Country Average | 0 | GBX0.05 |
-100%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
GBX3B
|
/ |
Apr 2025
£152.4m
|
= |
|
|
GBX3B
|
/ |
Mar 2026
£149.3m
|
= |
|
|
GBX3B
|
/ |
Mar 2027
£154m
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| UK |
|
Assura PLC
LSE:AGR
|
1.5B GBP | 19.4 | 9.3 | |
| US |
|
Welltower Inc
NYSE:WELL
|
145B USD | 64.8 | 154.8 | |
| US |
|
Ventas Inc
NYSE:VTR
|
39.4B USD | 21.4 | 156.7 | |
| US |
|
Omega Healthcare Investors Inc
NYSE:OHI
|
13.7B USD | 16.7 | 23.9 | |
| US |
|
Physicians Realty Trust
NYSE:DOC
|
11.4B USD | 12.8 | 162.2 | |
| US |
H
|
Healthpeak Properties Inc
F:HC5
|
9.7B EUR | 12.7 | 161.6 | |
| US |
C
|
CareTrust REIT Inc
NYSE:CTRE
|
8.5B USD | 22.1 | 26.4 | |
| BE |
|
Aedifica NV
XBRU:AED
|
6.1B EUR | 25.4 | 24.9 | |
| US |
|
Healthcare Realty Trust Inc
NYSE:HR
|
6.5B USD | 15.9 | -26.3 | |
| US |
H
|
Healthcare Trust Of America Inc
F:HT01
|
5.3B EUR | 20.1 | 66.4 | |
| US |
|
Sabra Health Care REIT Inc
NASDAQ:SBRA
|
5B USD | 16.7 | 32.1 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0 |
| Median | 0 |
| 70th Percentile | 0 |
| Max | 743.2 |
Other Multiples
Assura PLC
Glance View
In the ever-evolving landscape of healthcare infrastructure, Assura PLC has carved out a niche, specializing in the development and management of primary care properties across the UK. With a keen understanding of the public and private sector disparities within the healthcare industry, Assura operates essentially as a real estate investment trust (REIT), focusing on assets that provide essential healthcare services. Their business model is grounded in creating and maintaining robust and modern facilities that serve as the backbone for general practitioners, dentists, and other community health services. By partnering with the National Health Service (NHS), Assura ensures that these facilities not only meet current standards but also anticipate future healthcare needs, ensuring long-term sustainability and growth opportunities. Revenue generation for Assura PLC primarily revolves around rental income derived from the leasing of these healthcare properties. With a portfolio spanning several hundred properties, Assura capitalizes on long-term leases, often with inflation-linked rent reviews, providing them with a stable and predictable income. This strategy affords them the advantage of minimizing vacancy risks, given their collaboration with the NHS and the ongoing demand for modern healthcare facilities. By focusing on niche real estate like medical centers and community hospitals, Assura aligns its financial objectives with the critical needs of public health infrastructure, positioning itself as an essential player in ensuring the organic expansion of primary healthcare services throughout the UK.